Related Experiment Video

Updated: Aug 7, 2026

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

Vitamin D receptor agonists: opportunities and challenges in drug discovery

Tadakatsu Takahashi1, Kazumi Morikawa

  • 1Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd. 1-135 Komakado, Gotemba, Shizuoka 412-8513, Japan. takahashitdk@chugai-pharm.co.jp

Current Topics in Medicinal Chemistry
|July 20, 2006
PubMed

Insights

New vitamin D derivatives are being developed to treat various diseases by targeting the vitamin D receptor (VDR). These novel compounds aim to minimize side effects like hypercalcemia, offering a wider therapeutic window for conditions such as psoriasis and osteoporosis.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Pharmacology

Background:

  • 1alpha,25-dihydroxyvitamin D3 (1,25(OH)2D3) is a crucial hormone regulating calcium and phosphorus metabolism via the vitamin D receptor (VDR).
  • VDR is expressed in multiple organs, including the intestine, kidney, and bone, mediating diverse biological effects beyond calcium homeostasis.
  • 1,25(OH)2D3 exhibits differentiation induction, antiproliferative, immunomodulatory effects, and regulates cytokine and parathyroid hormone secretion.

Purpose of the Study:

  • To review recent advancements in the development of novel vitamin D derivatives.
  • To explore new vitamin D analogs with improved therapeutic profiles for clinical applications.
  • To address the limitations of current vitamin D therapies, specifically hypercalcemia and hypercalciuria.

Main Methods:

  • Review of current literature on vitamin D derivative research.
  • Analysis of the development of new vitamin D analogs.
  • Focus on derivatives with reduced calcemic effects and expanded therapeutic windows.

Main Results:

  • Current vitamin D derivatives are used for psoriasis, secondary hyperparathyroidism, and osteoporosis.
  • Hypercalcemia and hypercalciuria remain significant challenges with existing treatments.
  • Emerging vitamin D derivatives show promise for enhanced therapeutic efficacy and safety.

Conclusions:

  • Novel vitamin D derivatives are essential for expanding therapeutic applications.
  • Developing analogs with weak calcemic effects is a key research focus.
  • These new derivatives hold potential for treating a wider range of diseases with improved safety profiles.

More Related Videos

Methodology for Studying Interactions of Vitamin A Membrane Receptors and Opsin Protein with their Ligands in Generating the Retinylidene Protein08:18

Methodology for Studying Interactions of Vitamin A Membrane Receptors and Opsin Protein with their Ligands in Generating the Retinylidene Protein

Published on: October 4, 2024

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Principles of Drug Action01:24

Principles of Drug Action

Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...